+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopreservation Media Providers Market by Preservation Condition/Deep Frozen, and Cryogenic/LN2 Vapor Phase Storage), Type of Serum, Type of Biological Sample, Area of Application, Type of Packaging Format, End Users, and Region: Industry Trends and Global Forecasts, 2021-2035

  • PDF Icon

    Report

  • 197 Pages
  • January 2022
  • Region: Global
  • Roots Analysis
  • ID: 5557569
Over the past few years, there has been an evident growth in the pipeline of cell-based products, fueled by the demand for effective therapeutics. However, such products are often temperature sensitive, requiring freezing / cryogenic conditions for transport and storage. In fact, as per a study conducted by the USFDA, across more than 80% submissions for mesenchymal cell-based therapies, it was reported that such products required cryopreservation. Therefore, there is a need to identify preservation strategies that are capable of potentially protecting the genome and proteome while avoiding stress-related genetic selectivity, which is a condition that most of the current preservation methods fail to meet. Further, the chosen method should enable speedy restoration to normal physiological function. Specifically, the presence of components, such as animal-derived products, serum and proteins, often acts as a bottleneck for the effective preservation of biological samples. Biopreservation can address a number of product-related concerns by successfully combining engineering concepts with advances in cellular and molecular biology. As a result, there has been a shift in the interest of industry stakeholders towards pre-formulated, commercially available biopreservation media, which have already been checked for their quality, efficacy, safety, post preservation high cell recovery, clinical applicability and cost effectiveness.

At present, over 60 players claim to offer more than 190 biopreservation media, intended for storage and preservation of different types of biological samples. Recent trends indicate that the biopreservation media market is expanding at a rapid rate, as improvements in adjacent disciplines, such as stem-cell research, cell therapy, personalized medicine, cell banking and cancer research, are fueling the need for ameliorated storage techniques for biologics. For instance, Kite Pharma enhanced the stability of its primary oncological product (axacabtagene ciloleucel) from 18 hours to 2 weeks, by transitioning the product to cryopreserved state, easing production limitations and giving logistical flexibility at a lower overall cost. This further provides an opportunity for stakeholders to bring ingenious, improved and relatively economical biopreservation media in the market. It is worth highlighting that the biopreservation media providers are collaborating with other players in the reparative medicine industry to ensure safe and reliable outcomes. Considering the ever-lasting need for storage and transport of biological samples, as well as supported by the continuous endeavors of the biopreservation media providers to improvise their portfolio, we anticipate an upsurge in the adoption of hypothermic biopreservation media and cryopreservation media, over the coming years.


Scope of the Report



The “Biopreservation Media Providers Market by Preservation Condition (Refrigerated, Frozen / Cold Chain, Frozen (Ultra-low) / Deep Frozen, and Cryogenic / LN2 Vapor Phase Storage), Type of Serum (Fetal Bovine Serum Containing Media, Fetal Calf Serum Containing Media, Human Serum Containing Media, and Serum Free Media), Type of Biological Sample (Germline Cells / Stem Cells, Organs, Somatic Cells, and Tissues), Area of Application (Diagnostic Use, Research and Development, and Therapeutic Use), Type of Packaging Format (Bags, Bottles, Vials, and Others), End Users (Academic and Research Institutes, Biobanks / Genebanks, Hospitals, Pharmaceutical and Biotechnology Companies, and Other End Users), and Region (North America, Europe, Asia, MENA, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2021-2035” report offers an elaborate study of the current scenario and future potential of the biopreservation media providers market, over the next fourteen years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in the domain of biopreservation media.


Amongst other elements, the report includes:


  • A detailed overview of the current biopreservation media providers’ landscape, including information on the year of establishment, company size, type of company and location of headquarters. In addition, it presents the current market landscape of biopreservation media based on several relevant parameters, such as preservation condition, type of serum, type of biological sample, area of application, type of packaging format, packaging volume and product price.
  • An in-depth analysis of the contemporary market trends, presented using five schematic representations, including [A] a world map representation highlighting the location of headquarters, [B] a 4D bubble chart comparing the leading players engaged in offering biopreservation media based on the parameters, such as year of establishment, company size, number of biopreservation media offered and region, [C] an insightful treemap representation of biopreservation media, distributed on the basis of preservation condition and area of application, [D] a grid representation illustrating the distribution of biopreservation media based on company size, region, preservation condition, type of serum and type of biological sample, and [E] a heat map representation of biopreservation media, distributed on the basis of minimum packaging volume and minimum price.
  • An in-depth company competitiveness analysis of biopreservation media providers, taking into consideration various relevant parameters, such as years of experience, product portfolio strength (in terms of preservation condition, presence of serum, type of biological sample, maximum packaging volume and area of application), and partnership activity (in terms of number of partnerships and type of agreements).
  • Elaborate profiles of various prominent players that are engaged in offering biopreservation media, featuring a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and key members of the executive team), recent developments and an informed future outlook.
  • An analysis of the partnerships that have been inked between various stakeholders in this domain, during the period 2015-2021, covering manufacturing and supply agreements, product distribution agreements, product development agreements, acquisitions and other agreements.
  • A Bowman’s strategy clock framework to understand the pricing strategy of the biopreservation media offered by the company along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the biopreservation media based upon its characteristics.



One of the key objectives of the report was to estimate the existing market size and future opportunities associated with biopreservation media over the next fourteen years. Based on multiple parameters, such as likely adoption trends, revenues of biopreservation media providers, and expected price variations for these media, we have provided an informed estimate on the evolution of the market for the period 2021-2035. The report also features the likely distribution of the current and forecasted opportunity within biopreservation media providers market across [A] preservation condition (cryogenic / LN2 vapor phase, frozen (ultra-low) / deep frozen, frozen / cold chain, and refrigerated), [B] type of serum (fetal bovine serum containing media, fetal calf serum containing media, human serum containing media, and serum free media), [C] type of biological sample (germline cells / stem cells, organs, somatic cells, and tissues), [D] area of application (diagnostic use, research and development, and therapeutic use), [E] type of packaging format (bags, bottles, vials, and others), [F] end users (academic and research institutes, biobanks / genebanks, hospitals, pharmaceutical and biotechnology companies, and other end users), and [G] region (North America, Europe, Asia, MENA, Latin America, and Rest of the World). In order to account for future uncertainties and to add robustness to our forecast model, we have provided three forecast scenarios, portraying the conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.


Key Questions Answered


  • Who are the key players engaged in offering biopreservation media?
  • What is the most likely preservation condition supported by the biopreservation media offered?
  • What are the key geographical regions where biopreservation media providers are located?
  • What partnership models are most commonly adopted by stakeholders engaged in the domain of biopreservation media?
  • What are the key factors influencing the price of biopreservation media?
  • What are the likely market opportunities for different types of biopreservation media in the emerging market?
  • What are the anticipated future trends related to biopreservation media providers’ market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
2.1. Chapter Overview
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biopreservation
3.3. Type of Biopreservation
3.3.1. Hypothermic Preservation
3.3.2. Cryopreservation
3.4. Applications of Biopreservation Media
3.5. Benefits and Limitations of Biopreservation Media
3.6. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Biopreservation Media Providers: Service Providers Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Type of Company
4.2.4. Analysis by Location of Headquarters
4.3. Biopreservation Media: Market Landscape
4.3.1. Analysis by Preservation Condition
4.3.2. Analysis by Type of Serum
4.3.3. Analysis by Type of Biological Sample
4.3.4. Analysis by Area of Application
4.3.5. Analysis by Type of Packaging Format
4.3.6. Analysis by Packaging Volume
4.3.7. Analysis by Product Price
5. KEY INSIGHTS
5.1. Chapter Overview
5.2. Analysis by Location of Headquarters (World Map Representation)
5.3. Analysis by Year of Establishment, Company Size, Number of Biopreservation Media
5.4. Analysis by Preservation Condition and Area of Application (Treemap Representation)
5.5. Analysis by Company Size, Region, Preservation Condition, Type of Serum and Type of Biological Sample (Grid Representation)
5.6. Analysis by Minimum Packaging Volume and Minimum Price (Heat Map Representation)
6. COMPANY COMPETITIVENESS
6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.3. Methodology
6.4. Benchmarking of Product Portfolio Strength
6.5. Benchmarking of Partnership Activity
6.6. Biopreservation Media Providers: Company Competitiveness Analysis
6.6.1. Company Competitiveness Analysis: Very Small Companies
6.6.2. Company Competitiveness Analysis: Small Companies
6.6.3. Company Competitiveness Analysis: Mid-Sized Companies
6.6.4. Company Competitiveness Analysis: Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. BioLife Solutions
7.2.1. Company Overview
7.2.2. Recent Developments and Future Outlook
7.3. Cell Applications
7.3.1. Company Overview
7.3.2. Recent Developments and Future Outlook
7.4. HiMedia Laboratories
7.4.1. Company Overview
7.4.2. Recent Developments and Future Outlook
7.5. Merck
7.5.1. Company Overview
7.5.2. Recent Developments and Future Outlook
7.6. Thermo Fischer Scientific
7.6.1. Company Overview
7.6.2. Recent Developments and Future Outlook
7.7. United States Biological
7.7.1. Company Overview
7.7.2. Recent Developments and Future Outlook
7.8. ZenBio
7.8.1. Company Overview
7.8.2. Recent Developments and Future Outlook
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Biopreservation Media Providers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.2.1. Analysis by Year and Type of Partnership
8.3.2.2. Analysis by Type of Partnership and Company Size
8.3.3. Analysis by Type of Partner
8.3.3.1. Analysis by Year of Partnership and Type of Partner
8.3.3.2. Analysis by Type of Partner and Type of Partnership
8.3.3.3. Analysis by Type of Partner and Company Size
8.3.4. Most Active Players: Analysis by Number of Partnerships
8.3.5. Regional Analysis
8.3.5.1. Local and International Deals
8.3.5.2. Intercontinental and Intracontinental Deals
8.3.5.3. Analysis by Location of Headquarters of Partner
8.3.5.4. Analysis by Location of Headquarters of Partner and Type of Partnership
9. BOWMAN CLOCK PRICING STRATEGY
9.1. Chapter Overview
9.2. Bowman Strategy Clock
9.2.1. Two Dimensions of Bowman Strategy Clock
9.2.2. Eight Positions on Bowman Strategy Clock
9.3. Framework
9.3.1. Methodology
9.3.2. Theoretical Framework and Price Evaluation Hypothesis
9.3.3. Results and Interpretation
9.3.3.1. Product Price Evaluation Matrix: Information on Preservation Condition
9.3.3.2. Product Price Evaluation Matrix: Information on Type of Serum
9.3.3.3. Product Price Evaluation Matrix: Information on Type of Biological Sample
9.3.3.4. Product Price Evaluation Matrix: Information on Minimum Packaging Volume
9.3.3.5. Product Price Evaluation Matrix: Information on Maximum Packaging Volume
9.3.3.6. Product Price Evaluation Matrix: Information on Packaging Format
9.3.3.7. Product Price Evaluation Matrix: Information on Area of Application
9.3.4. Concluding Remarks
10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Biopreservation Media Providers Market, 2021-2035
10.4. Biopreservation Media Providers Market: Distribution by Preservation Condition, 2021 and 2035
10.4.1. Biopreservation Media Providers Market for Cryogenic / LN2 Vapor Phase, 2021-2035
10.4.2. Biopreservation Media Providers Market for Frozen (Ultra-low) / Deep Frozen, 2021-2035
10.4.3. Biopreservation Media Providers Market for Frozen / Cold Chain, 2021-2035
10.4.4. Biopreservation Media Providers Market for Refrigerated, 2021-2035
10.5. Biopreservation Media Providers Market: Distribution by Type of Serum, 2021 and 2035
10.5.1. Biopreservation Media Providers Market for Fetal Bovine Serum Containing Media, 2021-2035
10.5.2. Biopreservation Media Providers Market for Fetal Calf Serum Containing Media, 2021-2035
10.5.3. Biopreservation Media Providers Market for Human Serum Containing Media, 2021-2035
10.5.4. Biopreservation Media Providers Market for Serum Free Media, 2021-2035
10.6. Biopreservation Media Providers Market: Distribution by Type of Biological Sample, 2021 and 2035
10.6.1. Biopreservation Media Providers Market for Germline Cells / Stem Cells, 2021-2035
10.6.2. Biopreservation Media Providers Market for Organs, 2021-2035
10.6.3. Biopreservation Media Providers Market for Somatic Cells, 2021-2035
10.6.4. Biopreservation Media Providers Market for Tissues, 2021-2035
10.7. Biopreservation Media Providers Market: Distribution by Area of Application, 2021 and 2035
10.7.1. Biopreservation Media Providers Market for Diagnostic Use, 2021-2035
10.7.2. Biopreservation Media Providers Market for Research and Development, 2021-2035
10.7.3. Biopreservation Media Providers Market for Therapeutic Use, 2021-2035
10.8. Biopreservation Media Providers Market: Distribution by Type of Packaging Format, 2021 and 2035
10.8.1. Biopreservation Media Providers Market for Bags, 2021-2035
10.8.2. Biopreservation Media Providers Market for Bottles, 2021-2035
10.8.3. Biopreservation Media Providers Market for Vials, 2021-2035
10.8.4. Biopreservation Media Providers Market for Others, 2021-2035
10.9. Biopreservation Media Providers Market: Distribution by End Users, 2021 and 2035
10.9.1. Biopreservation Media Providers Market for Academic and Research Institutes, 2021-2035
10.9.2. Biopreservation Media Providers Market for Biobanks / Genebanks, 2021-2035
10.9.3. Biopreservation Media Providers Market for Hospitals, 2021-2035
10.9.4. Biopreservation Media Providers Market for Pharmaceutical and Biotechnology Companies, 2021-2035
10.9.5. Biopreservation Media Providers Market for Other End Users, 2021-2035
10.10. Biopreservation Media Providers Market: Distribution by Region, 2021 and 2035
10.10.1. Biopreservation Media Providers Market in North America, 2021-2035
10.10.2. Biopreservation Media Providers Market in Europe, 2021-2035
10.10.3. Biopreservation Media Providers Market in Asia, 2021-2035
10.10.4. Biopreservation Media Providers Market in MENA, 2021-2035
10.10.5. Biopreservation Media Providers Market in Latin America, 2021-2035
10.10.6. Biopreservation Media Providers Market in Rest of the World, 2021-2035
10.11. Concluding Remarks
11. CONCLUSION
11.1. Chapter Overview
12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. Cytes Biotechnologies
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Robert Gobern, Marketing Director
13. APPENDIX I: TABULATED DATA14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

Companies Mentioned

  • Adaptimmune Therapeutics
  • Akron Biotech
  • Alchimia
  • ALSTEM
  • American Type Culture Collection
  • Appleton Woods 
  • Applied Biological Materials
  • Athena Environmental Sciences
  • Aurolab
  • AvantBio 
  • Bausch & Lomb
  • Bellicum Pharmaceuticals
  • BioLife Solutions
  • Biological Industries
  • Bio-Rad Laboratories
  • Bio-Techne
  • BioVerde  
  • BPS Bioscience
  • Brooks Life Sciences
  • Caltag Medsystems
  • Capricorn Scientific 
  • Cell Applications
  • Cell Biologics
  • CELLnTEC Advanced Cell Systems
  • Cellular Biomedicine Group
  • Cellular Engineering Technologies
  • Cellular Technology 
  • Celprogen
  • Celyad
  • Charter Medical
  • chemQ bioscience
  • CLS Cell Lines Service
  • Cook MyoSite
  • Creative Bioarray
  • Creative Diagnostics
  • CryoCrate
  • Cryoport
  • Cyagen Biosciences
  • Cytes Biotechnologies
  • Cytiva
  • FroggaBio
  • Fujifilm
  • GCLYMPHOTEC 
  • Gemini Bio
  • GenDEPOT 
  • Genekam Biotechnology
  • Genlantis
  • HiMedia Laboratories
  • ibidi
  • INCELL
  • Iovance Biotherapeutics
  • Irvine Scientific Sales Company
  • IS Japan
  • Kiadis Pharma
  • Kite Pharma
  • KOLON Life Science
  • Kolon TissueGene
  • Lifeline Cell Technology
  • Lonza
  • Merck KGaA
  • Miltenyi Biotec
  • MP Biomedicals
  • Mustang Bio
  • Nacalai Tesque
  • Neuromics
  • Promethera Biosciences
  • PromoCell
  • Protide Pharmaceuticals
  • Quality Biological
  • R&D Systems
  • Revive Organtech
  • Santa Cruz Biotechnology
  • Sartorius
  • ScienCell Research Laboratories
  • Sigma-Aldrich
  • STEM ALPHA
  • STEMCELL Technologies
  • Sulfateq
  • TC BioPharm 
  • Thermo Fisher Scientific
  • United States Biological 
  • Valiant
  • VWR International
  • WakenBtech 
  • Worcester Polytechnic Institute
  • ZenBio
  • ZENOAQ

Methodology

 

 

Loading
LOADING...